Lobo Christopher MD is categorized under Internal Medicine Doctors in Media, PA and active since 2011.
Lobo Christopher MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Christopher Lobo at the company’s single location by writing to 1098 West Baltimore Pike # 3106, Media, Pennsylvania PA 19063 or by phoning (610) 627-4007. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lobo Christopher MD |
| Contact Person: | Christopher Lobo |
| Address: | 1098 West Baltimore Pike # 3106, Media, Pennsylvania 19063 |
| Phone Number: | (610) 627-4007 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Lobo Christopher MD was started in 2011 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Christopher Lobo for inquiries that concern Lobo Christopher MD by calling the company number (610) 627-4007, as your correspondence is most welcome. Additionally, the physical location of the single location of Lobo Christopher MD can be found at the coordinates 39.913948,-75.432332 as well as the street address 1098 West Baltimore Pike # 3106 in Media, Pennsylvania 19063.
For its online presence, you may visit Lobo Christopher MD’s website at and engage with its social media outlets through on Twitter and on Facebook.